Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Inventory Average (2016 - 2025)

Arcadia Biosciences filings provide 11 years of Inventory Average readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Inventory Average rose 53.48% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 53.48% increase, with the full-year FY2025 number at $1.1 million, up 21.54% from a year prior.
  • Inventory Average hit $1.3 million in Q4 2025 for Arcadia Biosciences, down from $1.5 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $4.9 million in Q4 2021 to a low of $869500.0 in Q4 2024.
  • Median Inventory Average over the past 5 years was $2.3 million (2021), compared with a mean of $2.4 million.
  • Biggest five-year swings in Inventory Average: surged 85.35% in 2022 and later tumbled 68.85% in 2024.
  • Arcadia Biosciences' Inventory Average stood at $4.9 million in 2021, then plummeted by 42.68% to $2.8 million in 2022, then crashed by 38.3% to $1.7 million in 2023, then tumbled by 50.23% to $869500.0 in 2024, then soared by 53.48% to $1.3 million in 2025.
  • The last three reported values for Inventory Average were $1.3 million (Q4 2025), $1.5 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.